Pharmacological depletion of macrophages leads to a reduction in inflammation and senescence in aged murine kidneys
Immunobiology · 2026-11 · 231 (6) · 153259
DOI: 10.1016/j.imbio.2026.153259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2026-11. Verfasst von Milan R Stojiljkovic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Jena University Hospital, Friedrich-Schiller University Jena, Am Klinikum 1, Jena, 07747, Germany. Electronic address: milan…. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BMBF Bonn, DFG.
Abstract (Originalsprache)
Aging is associated with chronic low-grade inflammation and cellular senescence, and macrophages are thought to contribute to these changes in the kidney. This study examined whether pharmacological inhibition of colony-stimulating factor 1 receptor (CSF1R) with PLX5622 modulates age-associated inflammatory and senescence-related changes in murine kidneys. Young and aged wild-type mice were treated with low-dose or high-dose PLX5622, and kidneys were analyzed for macrophage abundance, inflammatory markers, senescence-associated markers, and kidney injury markers. Aged kidneys showed increased expression of p16, IL-6, CX3CR1, and LCN2, together with higher numbers of F4/80-positive macrophages. Additional immunohistochemical analyses demonstrated increased CSF1R and p16 expression in F4/80-positive cells and increased senescence-associated β-galactosidase activity in aged kidneys. High-dose PLX5622 significantly reduced macrophage numbers in young and aged kidneys and lowered CX3CR1 expression, but was associated with increased blood urea nitrogen levels. In contrast, low-dose PLX5622 partially reduced macrophage abundance and significantly decreased IL-6, TNF-α, CX3CR1, p16, and senescence-associated β-galactosidase activity in aged kidneys without increasing blood urea nitrogen, while TIM1 remained unchanged. These findings indicate that CSF1R-sensitive macrophage populations contribute to age-associated inflammatory and senescence-related changes in the kidney and suggest that partial macrophage depletion may attenuate these processes without overt evidence of renal toxicity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Jena University Hospital, Friedrich-Schiller University Jena, Am Klinikum 1, Jena, 07747, Germany. Electronic address: milan.stojiljkovic@med.uni-jena.de.
- Department of Neurology, Jena University Hospital, Friedrich-Schiller University Jena, Am Klinikum 1, Jena, 07747, Germany. Electronic address: christian.schmeer@med.uni-jena.de.
- Department of Neurology, Jena University Hospital, Friedrich-Schiller University Jena, Am Klinikum 1, Jena, 07747, Germany. Electronic address: otto.witte@med.uni-jena.de.
Förderung
- BMBF Bonn
- DFG
Zitieren
APA
Stojiljkovic, M. R., Schmeer, C., & Witte, O. W. (2026). Pharmacological depletion of macrophages leads to a reduction in inflammation and senescence in aged murine kidneys. Immunobiology, 231(6), 153259. https://doi.org/10.1016/j.imbio.2026.153259
Vancouver
Stojiljkovic MR, Schmeer C, Witte OW. Pharmacological depletion of macrophages leads to a reduction in inflammation and senescence in aged murine kidneys. Immunobiology. 2026;231(6):153259. doi:10.1016/j.imbio.2026.153259
BibTeX
@article{Stojiljkovic2026,
author = {Stojiljkovic, Milan R and Schmeer, Christian and Witte, Otto W},
title = {Pharmacological depletion of macrophages leads to a reduction in inflammation and senescence in aged murine kidneys},
journal = {Immunobiology},
year = {2026},
volume = {231},
number = {6},
pages = {153259},
doi = {10.1016/j.imbio.2026.153259}
}
EUVIMED